OVARIAN CANCER and US

An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.

“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein

Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label MuGard. Show all posts
Showing posts with label MuGard. Show all posts
Tuesday, April 03, 2012

financial: Access Pharmaceuticals Investor Call Tomorrow, Wednesday April 4th at... -- DALLAS and NEW YORK, April 3, 2012 /PRNewswire/ --

›
Access Pharmaceuticals Investor Call Tomorrow, Wednesday April 4th at... -- DALLAS and NEW YORK, April 3, 2012 /PRNewswire/ -- "....A...
Thursday, June 24, 2010

press release: Access Pharmaceuticals, Inc. Presents MuGard Clinical Experience at MASCC Conference - MarketWatch

›
"MuGard is indicated in Europe for the prevention and management of oral mucositis, and has been used by over 2,000 cancer patients glo...
Tuesday, June 15, 2010

MuGard (oral mucositis - U.S.) Access Pharma Initiates US MuGard Sampling Program with Leading Oncology Groups - MarketWatch

›
"...Sampling efforts for the company include providing large oncology groups with MuGard kits containing six weeks' worth of MuGard...
›
Home
View web version

Sandi Pniauskas Ovarian Cancer and Us

OvarianCancerandUs
View my complete profile
Powered by Blogger.